Oncology Business Unit Director at Bristol-Myers Squibb

Israel

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Oncology, HealthcareIndustries

Requirements

Demonstrated leadership experience in oncology or related therapeutic areas, with a history of delivering measurable results such as revenue growth, successful product launches, or market share gains
Exceptional strategic thinking, analytical, and commercial skills, with the ability to translate actionable insights into comprehensive business plans
Excellent communication and stakeholder management capabilities, with a proven ability to engage and influence diverse internal and external partners
Strong record of cross-functional collaboration resulting in successful business outcomes

Responsibilities

Lead the oncology business unit by setting a clear strategic direction and executing robust commercial plans designed to maximize market footprint, deliver revenue growth, and expand market share
Manage P&L responsibilities, accurately forecast performance, and consistently deliver on quarterly and annual targets, demonstrating a proven track record of financial accountability and operational excellence
Collaborate closely with medical, access, and regulatory teams to develop and implement innovative strategies that optimize brand performance, ensure product launches are executed successfully, and ultimately improve patient outcomes
Proactively navigate compliance and risk management in the oncology sector, adhering to internal and external standards, and ensuring all business activities meet regulatory requirements
Develop, mentor, and empower team members, fostering a high-performance culture by supporting professional growth and recognizing outstanding contributions
Represent the oncology business in key internal forums and external engagements, building and nurturing strong partnerships to enhance the organization’s reputation within the industry and achieve successful, collaborative outcomes

Skills

P&L Management

Strategic Planning

Commercial Strategy

Revenue Forecasting

Market Share Expansion

Product Launch

Compliance Management

Risk Management

Team Leadership

Mentoring

Oncology

Pharmaceuticals

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free